Genomic Health, Inc. (GHDX) Financial Statements (2024 and earlier)

Company Profile

Business Address 301 PENOBSCOT DRIVE
REDWOOD CITY, CA 94063
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:243,809206,226214,132183,263152,945130,387
Cash and cash equivalents90,925101,40661,64569,24253,84742,085
Short-term investments152,625104,551148,149114,02199,09888,302
Other undisclosed cash, cash equivalents, and short-term investments2592694,338   
Receivables54,30759,24851,53151,55348,98246,567
Other undisclosed current assets14,11015,1779,17311,88613,44914,035
Total current assets:312,226280,651274,836246,702215,376190,989
Noncurrent Assets
Operating lease, right-of-use asset51,926 
Property, plant and equipment43,09839,91339,53239,80440,05440,824
Long-term investments and receivables   4,066   
Long-term investments   4,066   
Other noncurrent assets18,91318,93115,93813,86013,58611,126
Other undisclosed noncurrent assets  53,295    
Total noncurrent assets:113,937112,13959,53653,66453,64051,950
TOTAL ASSETS:426,163392,790334,372300,366269,016242,939
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities49,66244,73359,17649,98039,64738,305
Employee-related liabilities26,09122,03934,45729,13221,75021,913
Accounts payable6,6839,2908,8496,5455,1924,744
Accrued liabilities16,88813,40415,87014,30312,70511,648
Debt4,442     
Other liabilities260258600425340343
Other undisclosed current liabilities  4,495    
Total current liabilities:54,36449,48659,77650,40539,98738,648
Noncurrent Liabilities
Long-term debt and lease obligation:52,423     
Liabilities, other than long-term debt2,1551,9414,4363,9443,8263,899
Other liabilities2,1551,9414,4363,9443,8263,899
Operating lease, liability52,423 
Total noncurrent liabilities:54,5781,9414,4363,9443,8263,899
Total liabilities:108,94251,42764,21254,34943,81342,547
Equity
Equity, attributable to parent317,221287,881270,160246,017225,203200,392
Common stock333333
Treasury stock, value  (30,110)(30,110)(30,110)(30,110)(30,110)
Additional paid in capital524,551511,265506,679491,409482,835466,424
Accumulated other comprehensive income (loss)11649(87)(50)(65)(148)
Accumulated deficit(207,449)(193,326)(206,325)(215,235)(227,460)(235,777)
Total equity:317,221287,881270,160246,017225,203200,392
Other undisclosed liabilities and equity  53,482    
TOTAL LIABILITIES AND EQUITY:426,163392,790334,372300,366269,016242,939

Income Statement (P&L) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Revenues114,140108,769104,609101,25895,61992,625
Cost of revenue(17,674)(17,008)(706)(15,518)(14,383)(18,733)
Gross profit:96,46691,761103,90385,74081,23673,892
Operating expenses(80,968)(80,222)(94,477)(73,982)(74,136)(78,280)
Operating income (loss):15,49811,5399,42611,7587,100(4,388)
Nonoperating income1,1301,278560715152726
Investment income, nonoperating1,3341,151893676400417
Other nonoperating income (expense)(204)127(333)39(248)309
Interest and debt expense(4)     
Income (loss) from continuing operations before equity method investments, income taxes:16,62412,8179,98612,4737,252(3,662)
Other undisclosed income (loss) from continuing operations before income taxes(297)449(663)1271,283127
Income (loss) from continuing operations before income taxes:16,32713,2669,32312,6008,535(3,535)
Income tax expense(340)(267)(413)(375)(218)(240)
Income (loss) from continuing operations:15,98712,9998,91012,2258,317(3,775)
Income (loss) before gain (loss) on sale of properties:15,98712,9998,91012,2258,317(3,775)
Net income (loss) available to common stockholders, diluted:15,98712,9998,91012,2258,317(3,775)

Comprehensive Income ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Net income (loss):15,98712,9998,91012,2258,317(3,775)
Comprehensive income (loss):15,98712,9998,91012,2258,317(3,775)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent67136(37)1583(34)
Comprehensive income (loss), net of tax, attributable to parent:16,05413,1358,87312,2408,400(3,809)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: